Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

Erratum to: Regorafenib in Japanese patients with solid tumors: phase I study of safety, efficacy, and pharmacokinetics

Por Sunakawa, Yu, Furuse, Junji, Okusaka, Takuji, Ikeda, Masafumi, Nagashima, Fumio, Ueno, Hideki, Mitsunaga, Shuichi, Hashizume, Kensei, Ito, Yuichiro, Sasaki, Yasutsuna
Publicado em 2013

A comparison of four methods for detecting KRAS mutations in formalin-fixed specimens from metastatic colorectal cancer patients

Por MATSUNAGA, MOTOTSUGU, KANETA, TOSHIKADO, MIWA, KEISUKE, ICHIKAWA, WATARU, FUJITA, KEN-ICHI, NAGASHIMA, FUMIO, FURUSE, JUNJI, KAGE, MASAYOSHI, AKAGI, YOSHITO, SASAKI, YASUTSUNA
Publicado no Oncol Lett (2016)

Gender-specific genomic profiling in metastatic colorectal cancer patients treated with 5-fluorouracil and oxaliplatin

Por Gordon, Michael A, Zhang, Wu, Yang, Dongyun, Iqbal, Syma, El-Khouiery, Anthony, Nagashima, Fumio, Lurje, Georg, Labonte, Melissa, Wilson, Peter, Sherrod, Andy, Ladner, Robert D, Lenz, Heinz-Josef
Publicado em 2011